King-Jones Heidy
SEC CIK 1794898 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | See Remarks | 3,245 | — | $2.48M | 2 | 2026-09-01 | 2026-09-01 |
Most active insiders at SYRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir | — | $399.66M |
| 2 | Turtle Cameron | CEO, Dir | — | $9.99M |
| 3 | HENDERSON MICHAEL THOMAS | Dir | — | $7.95M |
| 4 | Sloan Sheldon | Chief Medical Off | — | $7.35M |
| 5 | Burrows Scott L | CFO | — | $6.86M |
| 6 | King-Jones Heidy | See Remarks | — | $2.48M |
| 7 | Albers Jeffrey W. | Dir | — | $2.40M |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-03 21:34 | 2026-09-01+ | SYRE | Spyre Therapeutics, Inc. | King-Jones Heidy | See Remarks | M - OptEx | $14.50 | +28.4K | 3,245 | New | +$411.8K |
| DMT | 2026-09-03 21:34 | 2026-09-01+ | SYRE | Spyre Therapeutics, Inc. | King-Jones Heidy | See Remarks | S - Sale+OE | $87.35 | -28.4K | 2,845 | -91% | -$2.48M |
Purchase Sale Sale after option exercise All abbreviations